Publication | Closed Access

Bioactive constituents and the molecular mechanism of Curcumae Rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking

Molecular PharmacologyMedicinePharmacologyPharmacological AgentPharmacotherapyBioactive ConstituentsMolecular DockingCurcumae RhizomaDrug Discovery